ArticleHealth services research2018
Geographic Disparities in Availability of Opioid Use Disorder Treatment for Medicaid Enrollees.
Article in Health services research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed.
- How Did Medicaid's 1115 Substance Use Disorder Waivers Increase Medication Treatment for Opioid Use Disorder? Evidence From Eight Waiver States.The Milbank quarterly · 2025Article
- Justice Core: An Innovative Response to Incarceration During Pregnancy in North Carolina.Journal of correctional health care : the official journal of the National Commission on Correctional Health Care · 2025Article
- Opioid Use Disorder Cascade of Care Among People Who Experienced Perinatal Incarceration: A Qualitative Study.Substance use & addiction journal · 2025Article
- Factors affecting waiting times to enter opioid use disorder treatment in the United States with a particular focus on potential biological sex disparity.PCN reports : psychiatry and clinical neurosciences · 2025Article
- Receipt of Medications for Alcohol and Opioid Use Disorders: The Importance of Service Utilization Patterns.The journal of behavioral health services & research · 2025Article
- Transitions of care between jail-based medications for opioid use disorder and ongoing treatment in the community: A retrospective cohort study.Drug and alcohol dependence · 2024Article
- Simulated impact of medicaid expansion on the economic burden of opioid use disorder in North Carolina.The International journal on drug policy · 2024Article
- Introduction of Medicare coverage in opioid treatment programs: Findings from the first three years.Journal of substance use and addiction treatment · 2024Article
- Availability of Medication for Opioid Use Disorder Among Accountable Care Organizations: Evidence From a National Survey.Psychiatric services (Washington, D.C.) · 2024Article
- Health Insurance and Mental Health Treatment Use Among Adults With Criminal Legal Involvement After Medicaid Expansion.Psychiatric services (Washington, D.C.) · 2023Article
- Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.Substance abuse · 2023Article
- Racial and ethnic disparities in emergency department-initiated buprenorphine across five health care systems.Academic emergency medicine : official journal of the Society for Academic Emergency Medicine · 2023Article
- Integrating MOUD and Primary Care: Outcomes of a Multicenter Learning Collaborative.Family medicine · 2023Article
- Changes In County-Level Access To Medications For Opioid Use Disorder After Medicare Coverage Of Methadone Treatment Began.Health affairs (Project Hope) · 2023Article
- Duration of medication for opioid use disorder during pregnancy and postpartum by race/ethnicity: Results from 6 state Medicaid programs.Drug and alcohol dependence · 2023Article
- Estimated Reductions in Opioid Overdose Deaths With Sustainment of Public Health Interventions in 4 US States.JAMA network open · 2023Article
- Geographic variations in opioid overdose patterns in Pennsylvania during the COVID-19 pandemic.Health & place · 2023Article
- Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder: A Review.JAMA psychiatry · 2023Review
- Substance Use Treatment Utilization Among Women With and Without Human Immunodeficiency Virus.Open forum infectious diseases · 2023Article
- Are North Carolina clinicians delivering opioid use disorder treatment to Medicaid beneficiaries?Addiction (Abingdon, England) · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo examine county-level geographic variation in treatment admissions among opioid treatment programs (OTPs) that accept Medicaid in the continental United States. DATA SOURCES/STUDY
settingData come from the 2012 National Survey of Substance Abuse Treatment Services. STUDY DESIGN/DATA COLLECTION: We used local measures of spatial autocorrelation (LISA) analysis to identify (1) clusters of counties with higher and lower than average rates of opioid use disorders and (2) clusters of counties with higher and lower than average treatment admissions among OTPs that accept Medicaid, adjusting for county population size. PRINCIPAL
findingsOur results reveal several clusters of counties with higher than average rates of opioid use disorder (OUD) and lower than average treatment admissions among OTPs that accept Medicaid. These clusters are highly concentrated in the Southeast region of the country and include Arkansas, Kentucky, Louisiana, Mississippi, and Tennessee.
conclusionsMedicaid enrollees in areas in the Southeast have the largest gaps between county-level OUD rates and estimated county-level capacity for treatment, as measured by county-level total treatment admissions among OTPs that accept Medicaid. Policy makers should consider strategies to increase the availability of OTPs with the capacity to serve Medicaid enrollees.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.